相关实验视频
Updated: Jun 22, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
技术在糖尿病中的进步 怀孕:正确的技术,正确的人,正确的时间
Anna McLean1,2, Louise Maple-Brown1,3, Helen R Murphy4,5
1Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia.
Diabetologia
|July 5, 2024
概括
最近的糖尿病技术,包括持续血糖监测 (CGM) 和混合闭环 (HCL) 系统,正在改变怀孕期间的1型糖尿病管理. 然而,只有CamAPS FX HCL系统对所有患有1型糖尿病的孕妇有已证明的好处.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 糖尿病技术 糖尿病技术
- 孕产妇和胎儿的医学
背景情况:
- 怀孕期间糖尿病管理在实现最佳血糖控制方面存在独特的挑战.
- 现有的糖尿病技术,如持续血糖监测 (CGM) 和胰岛素疗法,在达到严格的妊娠血糖目标方面存在局限性.
- 混合闭环 (HCL) 系统在怀孕期间有效,但在怀孕期间可能无法提供普遍的好处.
研究的目的:
- 审查最近糖尿病技术的进展,以管理怀孕前,怀孕期间和怀孕后的1型糖尿病.
- 评估特定的HCL系统,如CamAPS FX,在实现怀孕特定的血糖指数目标中的有效性.
- 突出关于2型糖尿病孕妇药物治疗和技术使用的知识差距.
主要方法:
- 关于糖尿病技术和怀孕管理的当前文献的综述.
- 分析证据支持使用CGM,胰岛素疗法和HCL系统在孕妇中.
- 确定研究检查药物治疗和技术的研究2型糖尿病在怀孕.
主要成果:
- 持续的葡萄糖监测 (CGM) 和胰岛素治疗单独不足以实现最佳的妊娠葡萄糖目标.
- 混合闭环 (HCL) 系统在怀孕期间的好处是特定于HCL系统,而不是怀孕之外的特定类别的好处.
- CamAPS FX HCL系统在所有母体葡萄糖类别中都表现出有效性,为所有患有1型糖尿病的孕妇提供了好处.
- 关于2型糖尿病孕妇的药物治疗和技术使用的研究有限.
结论:
- CamAPS FX HCL 系统是唯一一款具有强有力的证据证明在1型糖尿病孕妇中安全有效使用的 HCL 系统.
- 个性化的HCL算法和较低的葡萄糖目标对于优化怀孕期间糖尿病管理至关重要.
- 迫切需要进一步的研究,以探索2型糖尿病孕妇的药物治疗和技术选择.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Management and Pharmacotherapy
256
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
256
Pathophysiology of Diabetes
917
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
917
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes: Symptoms, Diagnosis, and Complications
521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521
Oral Hypoglycemic Agents: Biguanides and Glitazones
187
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
187

